Arrhythmia prophylaxis after aorta-coronary bypass. The effect of minidose propranolol

J Thorac Cardiovasc Surg. 1985 Mar;89(3):439-43.

Abstract

After aorta-coronary bypass grafting, 164 consecutive patients were randomized to receive propranolol 5 mg every 6 hours orally (n = 82) or to serve as control subjects (n = 82). All patients were receiving beta blockers preoperatively. There were no significant differences between the two groups. The incidence of sustained supraventricular (nonsinus) tachyarrhythmias was 23% in the control group and 9.8% in the treated group (p = 0.02). The incidence of ventricular arrhythmias was 15% in the control group and 2.4% in the treated group (p = 0.005). The overall difference in clinically important arrhythmias was 38% in the control group and 12.2% in the treated group (p = 0.0002). We conclude that low-dose oral propranolol in patients who were receiving beta blockers preoperatively is effective in reducing the incidence of clinically important arrhythmias occurring after aorta-coronary bypass grafting.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Arrhythmias, Cardiac / drug therapy
  • Arrhythmias, Cardiac / etiology
  • Arrhythmias, Cardiac / physiopathology
  • Arrhythmias, Cardiac / prevention & control*
  • Blood Pressure / drug effects
  • Coronary Artery Bypass / adverse effects*
  • Digoxin / administration & dosage
  • Digoxin / therapeutic use
  • Female
  • Heart Rate / drug effects
  • Humans
  • Male
  • Middle Aged
  • Preoperative Care
  • Propranolol / administration & dosage*
  • Propranolol / therapeutic use
  • Random Allocation

Substances

  • Digoxin
  • Propranolol